|

HALOZYME THERAPEUTICS INC (HALO)

US40637H1095 - Common Stock

39.69  +1.08 (+2.8%)

After market: 39.69 0 (0%)

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
253.90M202.10M402.70M129.10M-72.20M
Depreciation Amortization
71.30M49.60M3.00M3.30M4.10M
Income Taxes - Deferred
39.80M40.00M-155.40MN/AN/A
Change In Working Capital
-17.70M-86.00M3.70M-103.70M-50.50M
Interest Paid
N/A6.10M3.30M6.50M9.00M
Taxes Paid
N/A16.20M-400.00K200.00K200.00K
Other non cash items
21.40M34.30M45.40M26.80M33.30M
OPERATING CASH FLOW
368.60M240.10M299.40M55.50M-85.40M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-15.00M-4.80M-1.50M-2.50M-4.00M
Other Investing Activity
-75.30M-482.20M-404.80M80.90M-1.50M
INVESTING CASH FLOW
-90.30M-487.00M-406.30M78.40M-5.50M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
-13.50M624.50M415.80M-19.60M339.30M
Stock Issued/Repurchased
-137.70M-186.00M-337.50M-86.70M-185.80M
Other Financing Activity
N/A-76.20M-400.00K0.00-300.00K
FINANCING CASH FLOW
-151.70M362.40M77.90M-106.30M153.20M
 
CHANGE IN CASH
126.60M115.50M-29.00M27.60M62.30M
 
FREE CASH FLOW
Operating Cash Flow
368.60M240.10M299.40M55.50M-85.40M
Capital Expenditure
-15.00M-4.80M-1.50M-2.50M-4.00M
FREE CASH FLOW
353.60M235.30M297.90M53.00M-89.40M

All data in USD

Charts